BASF Venture Capital and Xiamen C&D are among the limited partners in Longwater Investment’s advanced materials-focused fund, which was already backed by Solvay.

Several university investors lined up to support sensory film supplier Forcen's seed round, with the proceeds allocated towards an expansion in production capacity and headcount.

Alphabet and Roc Nation-backed trading app developer Robinhood is reportedly looking to secure funding at a valuation of more than $7bn.

Cisco, Capital One and Citi exited the cybersecurity testing platform in a $250m deal that came in the wake of $33m in venture funding.

Alexandria Real Estate Equities-backed gene-edited seed developer Cibus has withdrawn its IPO application three months after setting a price range that would have raised $107m at the upper end.

Solid tumour treatment developer Atreca has set a $100m target for an initial public offering that will provide GlaxoSmithKline with an exit.

Personalis has filed to list on the Nasdaq Global Market through an offering that would come eight years after the genome sequencing platform was spun out of Stanford University.

Gil Ahrens, formerly head of venture capital and emerging growth coverage at Wells Fargo Securities, is set to reprise his role at Deutsche Bank.

Rohit Dave, previously senior director and head of M&A at WeWork, has ascended to vice-president and will continue heading M&A activities alongside running its Creator Fund.

Alphabet-backed spacecraft producer SpaceX has revealed more than $1bn in new funding, raised across two rounds sized at $486m and $535m respectively.